Semma Therapeutics
Acquired
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2014
- Business Model
- B2B
- Website
- semmatherapeutics.com
- Last Round
- Series BNov 2017
About
Semma Therapeutics was a Cambridge, Massachusetts-based biotechnology company founded in 2014 by Harvard stem cell biologist Douglas Melton. The company pioneered the use of stem cell-derived human islets as a potentially curative treatment for type 1 diabetes. Semma raised $158 million before being acquired by Vertex Pharmaceuticals in 2019 for $950 million.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account